Morgan Stanley Maintains Underweight on Embecta, Lowers Price Target to $13
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Cecilia Furlong maintains an Underweight rating on Embecta (NASDAQ:EMBC) and lowers the price target from $16 to $13.
May 10, 2024 | 3:36 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Morgan Stanley has maintained its Underweight rating on Embecta and reduced the price target from $16 to $13, indicating a bearish outlook.
The reduction in price target by a reputable analyst like Morgan Stanley suggests a negative outlook on Embecta's financial performance or market position, likely leading to a short-term decrease in stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100